Thursday, January 21, 2021 7:24:46 AM
schools and businesses, America must have wide-spread testing. A national
testing strategy is a cornerstone to reducing the spread of COVID-19 and
controlling outbreaks, and clear federal guidance and a unified national approach to
implementation are essential. The President will issue Executive Order Establishing
the National Pandemic Testing Board and Ensuring a Sustainable Public Health Workforce
for COVID-19 and Other Biological Threats which establishes the COVID-19 Pandemic
Testing Board to oversee implementation of a clear, unified approach to testing. The
federal government will expand the rapid testing supply and double test supplies
and increase testing capacity. The Administration will also increase onshore test
manufacturing, fill testing supply shortfalls, enhance laboratory capacity to conduct
testing over the short- and long-term, and expand surveillance for hotspots and
variants.
Effectively distribute tests and expand access to testing. The federal government
will support school screening testing programs to help schools reopen. The
Administration will also stand up a dedicated CDC Testing Support Team, fund rapid
test acquisition and distribution for priority populations, work to spur development
and manufacturing of at-home tests and work to ensure that tests are widely
available. Through Executive Order Establishing the National Pandemic Testing Board
and Ensuring a Sustainable Public Health Workforce for COVID-19 and Other Biological
Threats the President will direct agencies to facilitate testing free of charge for those
who lack health insurance and to clarify insurers’ obligation to cover testing. The
11 |
federal government will also provide testing protocols to inform the use of testing
in congregate settings, schools, and other critical areas and among asymptomatic
individuals. Further, technical assistance will support more widespread adoption of
testing to improve timely diagnosis and public confidence in the safety of settings like
schools.
Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.
Recent CODX News
- Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast • PR Newswire (US) • 04/25/2024 01:30:00 PM
- Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan • PR Newswire (US) • 04/24/2024 01:30:00 PM
- Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event • PR Newswire (US) • 04/12/2024 01:30:00 PM
- Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions • PR Newswire (US) • 04/04/2024 01:30:00 PM
- Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address • PR Newswire (US) • 03/21/2024 01:30:00 PM
- Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England • PR Newswire (US) • 03/18/2024 01:30:00 PM
- Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results • PR Newswire (US) • 03/14/2024 08:01:00 PM
- Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test • PR Newswire (US) • 03/07/2024 02:30:00 PM
- Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast • PR Newswire (US) • 02/29/2024 02:30:00 PM
- Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024 • PR Newswire (US) • 02/01/2024 02:30:00 PM
- Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12 • PR Newswire (US) • 01/03/2024 02:30:00 PM
- Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro • PR Newswire (US) • 12/27/2023 02:30:00 PM
- Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023 • PR Newswire (US) • 11/29/2023 02:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:50:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:38:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:37:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:05:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:01:35 PM
- Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results • PR Newswire (US) • 11/09/2023 09:01:00 PM
- Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development • PR Newswire (US) • 11/02/2023 01:30:00 PM
- Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023 • PR Newswire (US) • 10/31/2023 01:30:00 PM
- Co-Diagnostics, Inc. Announces Third Quarter 2023 Earnings Release Date and Webcast • PR Newswire (US) • 10/26/2023 01:30:00 PM
- Co-Diagnostics, Inc. to Host Booth at CASMET Symposium October 23-25 • PR Newswire (US) • 10/23/2023 01:30:00 PM
- Co-Diagnostics, Inc. to Host Booth at Medlab Africa 2023 in Johannesburg, South Africa • PR Newswire (US) • 10/16/2023 01:30:00 PM
- Co-Diagnostics, Inc. to Participate in the 2023 UHCA/UCAL Fall Convention & Expo on Sept 27-28 • PR Newswire (US) • 09/27/2023 01:30:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM